DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

414

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
03/11/26	€10.50	0.00%	37
02/11/26	€10.50	0.00%	0
30/10/26	€10.50	0.00%	86
29/10/26	€10.50	0.00%	50
28/10/26	€10.50	0.00%	0

Delayed Quote Xetra

More quotes

Market Closed - Xetra 20:35:22 03/11/2026 +04			5-day change	1st Jan Change
10.50 ^EUR	0.00%		0.00%	-14.63%

10-12	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI

Market Cap	53.28M 59.63M 48.94M 44.44M 83.46M 5.65B 85.56M 584M 235M 2.98B 224M 219M 9.45B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	35.69M 39.94M 32.78M 29.77M 55.91M 3.78B 57.31M 391M 157M 2B 150M 147M 6.33B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	27.93%	Yield 2024	8.98%	Yield 2025	8.13%

Markets		Quality
Xetra	AJ91	Delayed
Tradegate	AJ91	Real-time
Deutsche Boerse AG	AJ91	Delayed
Börse Stuttgart	AJ91	Delayed
Boerse Muenchen	AJ91	Real-time

10-12	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-09	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
10/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
14/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
29/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI

DocCheck AG Stock

Stocks

AJ91

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news: DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Quotes and Performance

Price Extremes

Managers and Directors: DocCheck AG

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
05/03/20	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

10-22	DocCheck Gruppe: Vorläufige Neunmonatszahlen
09-29	DocCheck : Halbjahresbericht 2026 PDF 3 MB
08-05	DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)

1 month	-1.87%
3 months	-8.70%
6 months	-22.79%
Current year	-14.63%

1 week	10.3	10.5
1 month	10.2	10.8
Current year	10.2	15.9
1 year	10.2	15.9
3 years	7	15.9
5 years	7	37.4
10 years	7	37.4

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	01/08/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	01/08/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	15/12/2014
Winfried Leimeister BRD	Director/Board Member	-	01/01/1999
Karin Immenroth BRD	Director/Board Member	-	31/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	0.00%	0.00%	-13.93%	+11.11%	59.67M
CVS HEALTH CORPORATION	+3.28%	+0.31%	+16.53%	+30.12%	113B
HCA HEALTHCARE, INC.	-1.04%	+2.87%	+0.28%	+100.51%	97.71B
NATERA, INC.	+2.56%	-5.40%	+96.05%	+809.29%	54.62B
FRESENIUS SE & CO. KGAA	+1.44%	+1.61%	-4.61%	+85.70%	30.65B
LABCORP HOLDINGS INC.	-0.47%	+6.87%	+37.26%	+68.36%	28.87B
QUEST DIAGNOSTICS INCORPORATED	-1.50%	+1.86%	+38.15%	+84.50%	27.59B
TENET HEALTHCARE CORPORATION	-0.82%	+1.77%	+32.42%	+385.60%	21.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-1.28%	-5.43%	-21.72%	-18.49%	19.74B
IHH HEALTHCARE	+0.52%	-0.38%	-5.80%	+29.78%	17.04B
Average	-0.44%	+0.49%	+17.46%	+158.65%	41.09B
Weighted average by Cap.	-1.05%	+0.64%	+22.63%	+177.08%

	2024	2025
Net sales	53.79M 60.2M 49.4M 44.87M 84.26M 5.7B 86.38M 590M 237M 3.01B 226M 221M 9.54B	55.32M 61.92M 50.81M 46.15M 86.66M 5.87B 88.84M 607M 244M 3.1B 232M 227M 9.81B
Net income	5.28M 5.91M 4.85M 4.41M 8.28M 560M 8.49M 57.93M 23.3M 296M 22.2M 21.72M 937M	5.33M 5.97M 4.9M 4.45M 8.36M 566M 8.57M 58.49M 23.53M 299M 22.41M 21.93M 946M
Net Debt	-20.11M -22.51M -18.47M -16.77M -31.5M -2.13B -32.29M -220M -88.69M -1.13B -84.48M -82.67M -3.57B	-17.59M -19.69M -16.16M -14.67M -27.56M -1.87B -28.25M -193M -77.58M -984M -73.9M -72.32M -3.12B